Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda snares approval for all-comer gastric cancer drug
Takeda snares approval for all-comer gastric cancer drug
Medical Marketing and Media
Takeda
Fruzaqla
colorectal cancer
Flag link:
Takeda Wins First FDA Approval for Ultra-Rare Blood Clotting Disease
Takeda Wins First FDA Approval for Ultra-Rare Blood Clotting Disease
BioSpace
Takeda
FDA
ADAMTS13
Adzynma
cogenital thrombocytopenic purpura
Flag link:
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
BioSpace
Takeda
fruquintinib
FDA
colorectal cancer
Flag link:
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
earnings
Bristol Myers Squibb
Takeda
Novartis
Sanofi
Merck
Flag link:
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Fierce Pharma
Novartis
Takeda
trade secrets
Flag link:
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023
BioSpace
Takeda
earnings
Flag link:
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
Takeda
Crohn's Disease
Alofisel
clinical trials
stem cells
Flag link:
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Takeda
AbbVie
Shire
M&A
legal
Flag link:
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Managed Healthcare Executive
Takeda
Exkivity
clinical trials
non-small cell lung cancer
Flag link:
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
BioSpace
FDA
BrainStorm Cell Therapeutics
NurOwn
Seelos Therapeutics
Takeda
Clene
Flag link:
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Pharmaceutical Technology
Takeda
Entyvio
ulcerative colitis
FDA
Flag link:
AcuraStem and Takeda Partner to Revolutionize ALS Treatment
AcuraStem and Takeda Partner to Revolutionize ALS Treatment
Best Stocks
Takeda
AcuraStem
ALS
AS-202
Flag link:
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Takeda
generics
gout
Colcrys
antitrust
Flag link:
Roche scores—again—in hemophilia drug patent case against Takeda
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Roche
Takeda
patents
legal
Genentech
Baxalta
hemophilia
Flag link:
AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
Fierce Pharma
AbbVie
Takeda
legal
Lupron
Flag link:
Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise
Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise
BioPharma Dive
Nimbus Therapeutics
Takeda
funding
cancer
Flag link:
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Flag link:
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Fierce Biotech
Takeda
Denali Therapeutics
Alzheimer's disease
clinical trials
Flag link:
FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed
FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed
BioSpace
Taiho Oncology
Lonsurf
colorectal cancer
FDA
Takeda
Hutchmed
Flag link:
Filings signal: Despite Covid losses, pharma earnings are promising
Filings signal: Despite Covid losses, pharma earnings are promising
Clinical Trials Arena
Takeda
AstraZeneca
Roche
earnings
COVID-19
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »